Female mice BALB/c (8 weeks) were obtained from the National Laboratory Animal Center (Taipei, Taiwan). The following animal protocol has been approved by the Institutional Animal Care and Use Committee of Taichung Veterans General Hospital (La-1111908; La-1121951). The BALB/c mice were housed on well-ventilated racks in a temperature- and humidity-controlled room under a regular light/dark cycle (light:dark = 12 h:12 h), and all had free access to rodent chow and tap water. Mice were randomly divided into five groups of six mice each. The groups included a wild type control, vehicle control (dimethyl sulfoxide,
DMSO, Sigma-Aldrich, St. Louis, MI, USA),
dexamethasone (1 mg/kg/day), D3T (Abcam, Fremont, CA, USA; 10 mg/kg/day), and D3T (Abcam, USA; 30 mg/kg/day).
DMSO,
dexamethasone, and D3T were administrated through intraperitoneal injection (i.p.), while 62.5 mg IMQ topical cream (Aldara
®, Somerset, NJ, USA) was applied to the shaved dorsal areas and ears for a period of five consecutive days. Psoriasis severities, including redness, scaling, ear thickness, and body weight were all evaluated daily prior to IMQ application. Scores were interpreted as follows: 0 = none, 1 = mild, 2 = moderate, 3 = severe, and 4 = very severe. The thickness of each mice ear was measured using a digital thickness gauge.
Shih M.C., Li C.L., Liao E.C., Yen C.Y., Yen L.J., Wang K.C., Lu L.Y., Chou T.Y., Chen Y.C, & Yu S.J. (2023). Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment. International Journal of Molecular Sciences, 24(17), 13528.